• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毛细血管血糖的生物学变异:一项系统评价。

Biological variation of capillary blood glucose: A systematic review.

作者信息

Zanette Kenia D, Martinello Flavia

机构信息

Department of Clinical Analyses, Federal University of Santa Catarina, Florianópolis, Santa Catarina 88040-370, Brazil.

出版信息

Biomed Rep. 2024 Oct 30;22(1):7. doi: 10.3892/br.2024.1885. eCollection 2025 Jan.

DOI:10.3892/br.2024.1885
PMID:39559818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11572030/
Abstract

Biological variation (BV) refers to changes in biochemical constituents in the blood or other biological fluids, indicative of body regulation via homeostatic processes. Intra- and interindividual BV data are essential for establishing analytical performance specifications and evaluating the significance between consecutive measurements of an analyte. Given this context, the present study conducted a systematic review of the intra- and interindividual BV of capillary blood glucose. Out of 461 initial studies identified, only 4 met the inclusion criteria for detailed analysis after excluding 419 for title irrelevance, 10 for duplication, 21 based on abstract content and 7 based on article content. Notably, none of the studies primarily focused on the intra- and interindividual BV of capillary blood glucose; rather, they reported it as a secondary outcome. Regarding fasting, data analyses revealed intra-individual BVs of 4.5 and 31.1% for healthy and diabetic individuals, respectively, and interindividual coefficient of variations of 4.7-5.8 and 12.9-16.3% for healthy and diabetic individuals, respectively. Only one study provided the analytical coefficient of variation, corroborating the recommended practices. Additionally, the fasting duration, meal standardization before sampling, and number and interval between collections varied among the studies. Hence, the results suggest that there are no reliable data on intra- and interindividual BVs for capillary blood glucose in the literature.

摘要

生物变异(BV)是指血液或其他生物体液中生化成分的变化,表明机体通过稳态过程进行调节。个体内和个体间的BV数据对于建立分析性能规范以及评估分析物连续测量值之间的差异具有重要意义。在此背景下,本研究对毛细血管血糖的个体内和个体间BV进行了系统综述。在最初确定的461项研究中,排除419项因标题无关、10项因重复、21项基于摘要内容以及7项基于文章内容后,仅有4项符合详细分析的纳入标准。值得注意的是,这些研究均未将毛细血管血糖的个体内和个体间BV作为主要关注点,而是将其作为次要结果进行报告。关于空腹情况,数据分析显示,健康个体和糖尿病个体的个体内BV分别为4.5%和31.1%,健康个体和糖尿病个体的个体间变异系数分别为4.7 - 5.8%和12.9 - 16.3%。仅有一项研究提供了分析变异系数,证实了推荐的做法。此外,各研究之间的禁食时长、采样前膳食标准化以及采集次数和间隔也有所不同。因此,结果表明,文献中尚无关于毛细血管血糖个体内和个体间BV的可靠数据。

相似文献

1
Biological variation of capillary blood glucose: A systematic review.毛细血管血糖的生物学变异:一项系统评价。
Biomed Rep. 2024 Oct 30;22(1):7. doi: 10.3892/br.2024.1885. eCollection 2025 Jan.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.用于 1 型和 2 型成年糖尿病患者群体的持续皮下胰岛素输注(CSII)泵:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(20):1-58. Epub 2009 Oct 1.
4
Variability of capillary plasma glucose in healthy individuals in repeated 75 g oral glucose tolerance tests.健康个体在重复进行75克口服葡萄糖耐量试验时毛细血管血浆葡萄糖的变异性。
Ann Clin Biochem. 1988 Nov;25 ( Pt 6):634-7. doi: 10.1177/000456328802500606.
5
Dietary glycation compounds - implications for human health.饮食糖化化合物 - 对人类健康的影响。
Crit Rev Toxicol. 2024 Sep;54(8):485-617. doi: 10.1080/10408444.2024.2362985. Epub 2024 Aug 16.
6
Establishing biological variation for plasma D-dimer from 25 healthy individuals.建立 25 名健康个体血浆 D-二聚体的生物学变异。
Scand J Clin Lab Invest. 2021 Oct;81(6):469-474. doi: 10.1080/00365513.2021.1947522. Epub 2021 Jul 8.
7
Evaluation of systematic and random factors in measurements of fasting plasma glucose as the basis for analytical quality specifications in the diagnosis of diabetes. 3. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus.评估空腹血糖测量中的系统因素和随机因素,作为糖尿病诊断中分析质量规范的基础。3. 世界卫生组织(WHO)和美国糖尿病协会(ADA)新建议对糖尿病诊断的影响。
Scand J Clin Lab Invest. 2001 May;61(3):191-204. doi: 10.1080/003655101300133630.
8
Nursing and midwifery management of hypoglycaemia in healthy term neonates.健康足月新生儿低血糖的护理和助产管理。
Int J Evid Based Healthc. 2005 Aug;3(7):169-205. doi: 10.1111/j.1479-6988.2005.00025.x.
9
Reducing unemployment benefit duration to increase job finding rates: a systematic review.缩短失业救济期限以提高就业找到率:一项系统综述
Campbell Syst Rev. 2018 Feb 28;14(1):1-194. doi: 10.4073/csr.2018.2. eCollection 2018.
10
Systematic review and meta-analysis of within-subject and between-subject biological variation data of coagulation and fibrinolytic measurands.系统回顾和荟萃分析凝血和纤溶测量指标的个体内和个体间生物学变异数据。
Clin Chem Lab Med. 2023 Feb 22;61(8):1470-1480. doi: 10.1515/cclm-2022-1207. Print 2023 Jul 26.

引用本文的文献

1
Personalized bleeding management in total knee arthroplasty using reference change value: comparative analysis of tourniquet versus non-tourniquet techniques.使用参考变化值进行全膝关节置换术中的个性化出血管理:止血带与非止血带技术的比较分析
Arch Orthop Trauma Surg. 2025 Jun 7;145(1):335. doi: 10.1007/s00402-025-05946-1.

本文引用的文献

1
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024.6. 血糖目标与低血糖:2024年糖尿病诊疗标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S111-S125. doi: 10.2337/dc24-S006.
2
16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2024.16. 医院中的糖尿病护理:2024 年糖尿病护理标准。
Diabetes Care. 2024 Jan 1;47(Suppl 1):S295-S306. doi: 10.2337/dc24-S016.
3
Diagnostic Accuracy of Capillary Blood Glucometer Testing for Gestational Diabetes.毛细血管血糖仪检测妊娠期糖尿病的诊断准确性
Diabetes Metab Syndr Obes. 2022 Dec 14;15:3855-3870. doi: 10.2147/DMSO.S389420. eCollection 2022.
4
Biological variation: recent development and future challenges.生物变异:最新进展与未来挑战
Clin Chem Lab Med. 2022 Dec 20;61(5):741-750. doi: 10.1515/cclm-2022-1255. Print 2023 Apr 25.
5
Managing biological variation data: modern approaches for study design and clinical application.管理生物学变异数据:研究设计和临床应用的现代方法。
Crit Rev Clin Lab Sci. 2021 Nov;58(7):493-512. doi: 10.1080/10408363.2021.1932718. Epub 2021 Jun 15.
6
Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients With Diabetes.德康 G6 连续血糖监测在非危重症住院糖尿病患者中的准确性。
Diabetes Care. 2021 Jul;44(7):1641-1646. doi: 10.2337/dc20-2856. Epub 2021 Jun 7.
7
The European Biological Variation Study (EuBIVAS): a summary report.欧洲生物学变异研究(EuBIVAS):总结报告。
Clin Chem Lab Med. 2021 May 31;60(4):505-517. doi: 10.1515/cclm-2021-0370. Print 2022 Mar 28.
8
Biological variation: Understanding why it is so important?生物变异:理解其为何如此重要?
Pract Lab Med. 2021 Jan 4;23:e00199. doi: 10.1016/j.plabm.2020.e00199. eCollection 2021 Jan.
9
6. Glycemic Targets: .6. 血糖目标: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S73-S84. doi: 10.2337/dc21-S006.
10
Personalized Reference Intervals in Laboratory Medicine: A New Model Based on Within-Subject Biological Variation.实验室医学中的个体化参考区间:基于个体内生物学变异的新模型。
Clin Chem. 2021 Jan 30;67(2):374-384. doi: 10.1093/clinchem/hvaa233.